INHIBIKASE THERAPEUTICS INC - COM (IKT)

CUSIP: 45719W106

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class: Equity / COM
Total 13F shares: 0
Share change: -13,802
Total reported value: $0
Number of holders: 0
Value change: -$50,000
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 45719W106?
CUSIP 45719W106 identifies IKT - INHIBIKASE THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q2 2023

Recent filing periods for CUSIP 45719W106:

Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021

There are no holders of IKT - INHIBIKASE THERAPEUTICS INC - COM as of Q3 2023.